Advancing medicines with continuous care.
MatraMeds is building therapeutic products for chronic and complex diseases and designing connected support around them to help improve adherence and day-to-day health management.
What continuous care means
We are building a drug + digital support approach for chronic diseases so that care can continue beyond the prescription, with planned support for adherence, patient engagement, routine follow-up, and better continuity across the treatment journey.
The surge in chronic disease is widening the gap between treatment and control.
Chronic diseases such as hypertension, diabetes, respiratory conditions and cancer affect very large populations globally. Yet long-term outcomes are influenced by more than treatment access alone. Across conditions, limited monitoring, fragmented care, poor adherence and gaps between consultations can reduce control and worsen long-term burden.
Access to treatment is only part of the picture.
Many patients still experience interrupted follow-up, limited monitoring, poor adherence, fragmented care, and delayed escalation between consultations. These gaps can make long-term disease control harder and add avoidable burden over time.
Limited monitoring
Fewer opportunities to identify deterioration early.
Fragmented care
Multiple steps between diagnosis, treatment and ongoing support.
Poor adherence
Missed doses, missed tests and missed follow-up.
High lifetime care cost
Complications and delayed intervention can increase burden for patients, families and health systems.
We are building a drug + digital support approach for long-term care.
Designed to support the journey after the prescription
MatraMeds is developing a model that combines therapeutic products with connected support designed to help strengthen adherence, patient engagement, routine follow-up, and continuity of care, while keeping treatment decisions with qualified healthcare professionals.
- adherence support
- engagement and education
- routine monitoring support
- continuity across visits and follow-up
Redefining what chronic care can feel like.
We are building a pharmaceutical company focused on improving how chronic diseases are treated and supported. Our aim is to combine therapeutic products with practical support systems that strengthen adherence, follow-up, patient understanding, and long-term engagement across cardio-metabolic, oncology, and respiratory care.
Together, we aim to move care beyond the prescription and towards a healthier, more connected future.
Why this matters
Better continuity can help support fewer missed doses, better prepared follow-up, clearer patient understanding, and stronger long-term engagement.